Established donepezil treatment modulates regional brain activation in early Alzheimer's disease

W J McGeown, M F Shanks, K E Forbes-McKay, G D Waiter, I Elrick, M G Venneri, A Venneri

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) have shown the different short and long term actions of ChEIs. fMRI studies of the ChEI donepezil have focused on its short to medium term action without exploring the effects of established treatment. In this exploratory study the effect of 20 weeks donepezil treatment on regional brain activity was measured with fMRI in patients with mild AD. Twelve patients with probable AD and nine age-matched controls were assessed with a Pyramids and Palm Trees semantic association fMRI paradigm and an n-back working memory fMRI paradigm. In the patient group only, the assessment was repeated after 20 weeks of treatment. After treatment, differences from normal healthy elderly became more pronounced. There was also a spread of deactivation which at retest was detectable in task relevant areas. Behaviourally, however, there were no significant differences between group baseline and retest scores, with a range of performance probably reflecting variation in drug efficacy across patients. Parametric analyses established that increased behavioural scores at retest correlated significantly with higher activation levels in non task relevant areas. Behavioural stability with donepezil treatment was not paralleled by the pattern of improved task specific brain activation reported in similar studies of other ChEIs. This is arguably related to the different mechanisms of action of the ChEIs and might be a clinical correlate of the reported synaptic upregulation following long term donepezil treatment.
Original languageEnglish
Pages (from-to)415-427
Number of pages18
JournalCurrent Alzheimer Research
Volume7
Issue number5
Publication statusPublished - Aug 2010

Fingerprint

Alzheimer Disease
Brain
Magnetic Resonance Imaging
Cholinesterase Inhibitors
Therapeutics
donepezil
Short-Term Memory
Semantics
Neuroimaging
Up-Regulation
Pharmaceutical Preparations

Keywords

  • fMRI
  • semantic
  • working memory
  • upregulation
  • pharmacodynamic

Cite this

McGeown, W. J., Shanks, M. F., Forbes-McKay, K. E., Waiter, G. D., Elrick, I., Venneri, M. G., & Venneri, A. (2010). Established donepezil treatment modulates regional brain activation in early Alzheimer's disease. Current Alzheimer Research, 7(5), 415-427.

Established donepezil treatment modulates regional brain activation in early Alzheimer's disease. / McGeown, W J; Shanks, M F; Forbes-McKay, K E; Waiter, G D; Elrick, I; Venneri, M G; Venneri, A.

In: Current Alzheimer Research, Vol. 7, No. 5, 08.2010, p. 415-427.

Research output: Contribution to journalArticle

McGeown, WJ, Shanks, MF, Forbes-McKay, KE, Waiter, GD, Elrick, I, Venneri, MG & Venneri, A 2010, 'Established donepezil treatment modulates regional brain activation in early Alzheimer's disease', Current Alzheimer Research, vol. 7, no. 5, pp. 415-427.
McGeown WJ, Shanks MF, Forbes-McKay KE, Waiter GD, Elrick I, Venneri MG et al. Established donepezil treatment modulates regional brain activation in early Alzheimer's disease. Current Alzheimer Research. 2010 Aug;7(5):415-427.
McGeown, W J ; Shanks, M F ; Forbes-McKay, K E ; Waiter, G D ; Elrick, I ; Venneri, M G ; Venneri, A. / Established donepezil treatment modulates regional brain activation in early Alzheimer's disease. In: Current Alzheimer Research. 2010 ; Vol. 7, No. 5. pp. 415-427.
@article{b94e70501bf0426ab1ae2947d7fc08af,
title = "Established donepezil treatment modulates regional brain activation in early Alzheimer's disease",
abstract = "Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) have shown the different short and long term actions of ChEIs. fMRI studies of the ChEI donepezil have focused on its short to medium term action without exploring the effects of established treatment. In this exploratory study the effect of 20 weeks donepezil treatment on regional brain activity was measured with fMRI in patients with mild AD. Twelve patients with probable AD and nine age-matched controls were assessed with a Pyramids and Palm Trees semantic association fMRI paradigm and an n-back working memory fMRI paradigm. In the patient group only, the assessment was repeated after 20 weeks of treatment. After treatment, differences from normal healthy elderly became more pronounced. There was also a spread of deactivation which at retest was detectable in task relevant areas. Behaviourally, however, there were no significant differences between group baseline and retest scores, with a range of performance probably reflecting variation in drug efficacy across patients. Parametric analyses established that increased behavioural scores at retest correlated significantly with higher activation levels in non task relevant areas. Behavioural stability with donepezil treatment was not paralleled by the pattern of improved task specific brain activation reported in similar studies of other ChEIs. This is arguably related to the different mechanisms of action of the ChEIs and might be a clinical correlate of the reported synaptic upregulation following long term donepezil treatment.",
keywords = "fMRI, semantic , working memory, upregulation, pharmacodynamic",
author = "McGeown, {W J} and Shanks, {M F} and Forbes-McKay, {K E} and Waiter, {G D} and I Elrick and Venneri, {M G} and A Venneri",
year = "2010",
month = "8",
language = "English",
volume = "7",
pages = "415--427",
journal = "Current Alzheimer Research",
issn = "1567-2050",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Established donepezil treatment modulates regional brain activation in early Alzheimer's disease

AU - McGeown, W J

AU - Shanks, M F

AU - Forbes-McKay, K E

AU - Waiter, G D

AU - Elrick, I

AU - Venneri, M G

AU - Venneri, A

PY - 2010/8

Y1 - 2010/8

N2 - Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) have shown the different short and long term actions of ChEIs. fMRI studies of the ChEI donepezil have focused on its short to medium term action without exploring the effects of established treatment. In this exploratory study the effect of 20 weeks donepezil treatment on regional brain activity was measured with fMRI in patients with mild AD. Twelve patients with probable AD and nine age-matched controls were assessed with a Pyramids and Palm Trees semantic association fMRI paradigm and an n-back working memory fMRI paradigm. In the patient group only, the assessment was repeated after 20 weeks of treatment. After treatment, differences from normal healthy elderly became more pronounced. There was also a spread of deactivation which at retest was detectable in task relevant areas. Behaviourally, however, there were no significant differences between group baseline and retest scores, with a range of performance probably reflecting variation in drug efficacy across patients. Parametric analyses established that increased behavioural scores at retest correlated significantly with higher activation levels in non task relevant areas. Behavioural stability with donepezil treatment was not paralleled by the pattern of improved task specific brain activation reported in similar studies of other ChEIs. This is arguably related to the different mechanisms of action of the ChEIs and might be a clinical correlate of the reported synaptic upregulation following long term donepezil treatment.

AB - Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) have shown the different short and long term actions of ChEIs. fMRI studies of the ChEI donepezil have focused on its short to medium term action without exploring the effects of established treatment. In this exploratory study the effect of 20 weeks donepezil treatment on regional brain activity was measured with fMRI in patients with mild AD. Twelve patients with probable AD and nine age-matched controls were assessed with a Pyramids and Palm Trees semantic association fMRI paradigm and an n-back working memory fMRI paradigm. In the patient group only, the assessment was repeated after 20 weeks of treatment. After treatment, differences from normal healthy elderly became more pronounced. There was also a spread of deactivation which at retest was detectable in task relevant areas. Behaviourally, however, there were no significant differences between group baseline and retest scores, with a range of performance probably reflecting variation in drug efficacy across patients. Parametric analyses established that increased behavioural scores at retest correlated significantly with higher activation levels in non task relevant areas. Behavioural stability with donepezil treatment was not paralleled by the pattern of improved task specific brain activation reported in similar studies of other ChEIs. This is arguably related to the different mechanisms of action of the ChEIs and might be a clinical correlate of the reported synaptic upregulation following long term donepezil treatment.

KW - fMRI

KW - semantic

KW - working memory

KW - upregulation

KW - pharmacodynamic

M3 - Article

VL - 7

SP - 415

EP - 427

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1567-2050

IS - 5

ER -